BACKGROUND:Whole grain wheat (WGW) consumption is associated with health benefits in observational studies. However, WGW randomized controlled trial (RCT) studies show mixed effects. OBJECTIVES: The health impact of WGW consumption was investigated by quantification of the body's resilience, which was defined as the "ability to adapt to a standardized challenge." METHODS: A double-blind RCT was performed with overweight and obese (BMI: 25-35 kg/m2) men (n = 19) and postmenopausal women (n = 31) aged 45-70 y, with mildly elevated plasma total cholesterol (>5 mmol/L), who were randomly assigned to either 12-wk WGW (98 g/d) or refined wheat (RW). Before and after the intervention a standardized mixed-meal challenge was performed. Plasma samples were taken after overnight fasting and postprandially (30, 60, 120, and 240 min). Thirty-one biomarkers were quantified focusing on metabolism, liver, cardiovascular health, and inflammation. Linear mixed-models evaluated fasting compared with postprandial intervention effects. Health space models were used to evaluate intervention effects as composite markers representing resilience of inflammation, liver, and metabolism. RESULTS: Postprandial biomarker changes related to liver showed decreased alanine aminotransferase by WGW (P = 0.03) and increased β-hydroxybutyrate (P = 0.001) response in RW. Postprandial changes related to inflammation showed increased C-reactive protein (P = 0.001), IL-6 (P = 0.02), IL-8 (P = 0.007), and decreased IL-1B (P = 0.0002) in RW and decreased C-reactive protein (P < 0.0001), serum amyloid A (P < 0.0001), IL-8 (P = 0.02), and IL-10 (P < 0.0001) in WGW. Health space visualization demonstrated diminished inflammatory (P < 0.01) and liver resilience (P < 0.01) by RW, whereas liver resilience was rejuvenated by WGW (P < 0.05). CONCLUSIONS: Twelve-week 98 g/d WGW consumption can promote liver and inflammatory resilience in overweight and obese subjects with mildly elevated plasma cholesterol. The health space approach appeared appropriate to evaluate intervention effects as composite markers. This trial was registered at www.clinicaltrials.gov as NCT02385149.
RCT Entities:
BACKGROUND: Whole grain wheat (WGW) consumption is associated with health benefits in observational studies. However, WGW randomized controlled trial (RCT) studies show mixed effects. OBJECTIVES: The health impact of WGW consumption was investigated by quantification of the body's resilience, which was defined as the "ability to adapt to a standardized challenge." METHODS: A double-blind RCT was performed with overweight and obese (BMI: 25-35 kg/m2) men (n = 19) and postmenopausal women (n = 31) aged 45-70 y, with mildly elevated plasma total cholesterol (>5 mmol/L), who were randomly assigned to either 12-wk WGW (98 g/d) or refined wheat (RW). Before and after the intervention a standardized mixed-meal challenge was performed. Plasma samples were taken after overnight fasting and postprandially (30, 60, 120, and 240 min). Thirty-one biomarkers were quantified focusing on metabolism, liver, cardiovascular health, and inflammation. Linear mixed-models evaluated fasting compared with postprandial intervention effects. Health space models were used to evaluate intervention effects as composite markers representing resilience of inflammation, liver, and metabolism. RESULTS: Postprandial biomarker changes related to liver showed decreased alanine aminotransferase by WGW (P = 0.03) and increased β-hydroxybutyrate (P = 0.001) response in RW. Postprandial changes related to inflammation showed increased C-reactive protein (P = 0.001), IL-6 (P = 0.02), IL-8 (P = 0.007), and decreased IL-1B (P = 0.0002) in RW and decreased C-reactive protein (P < 0.0001), serum amyloid A (P < 0.0001), IL-8 (P = 0.02), and IL-10 (P < 0.0001) in WGW. Health space visualization demonstrated diminished inflammatory (P < 0.01) and liver resilience (P < 0.01) by RW, whereas liver resilience was rejuvenated by WGW (P < 0.05). CONCLUSIONS: Twelve-week 98 g/d WGW consumption can promote liver and inflammatory resilience in overweight and obese subjects with mildly elevated plasma cholesterol. The health space approach appeared appropriate to evaluate intervention effects as composite markers. This trial was registered at www.clinicaltrials.gov as NCT02385149.
Authors: Paola Vitaglione; Ilario Mennella; Rosalia Ferracane; Angela A Rivellese; Rosalba Giacco; Danilo Ercolini; Sean M Gibbons; Antonietta La Storia; Jack A Gilbert; Satya Jonnalagadda; Frank Thielecke; Maria A Gallo; Luca Scalfi; Vincenzo Fogliano Journal: Am J Clin Nutr Date: 2014-12-03 Impact factor: 7.045
Authors: Machteld Huber; J André Knottnerus; Lawrence Green; Henriëtte van der Horst; Alejandro R Jadad; Daan Kromhout; Brian Leonard; Kate Lorig; Maria Isabel Loureiro; Jos W M van der Meer; Paul Schnabel; Richard Smith; Chris van Weel; Henk Smid Journal: BMJ Date: 2011-07-26
Authors: Alwine F M Kardinaal; Marjan J van Erk; Alice E Dutman; Johanna H M Stroeve; Evita van de Steeg; Sabina Bijlsma; Teake Kooistra; Ben van Ommen; Suzan Wopereis Journal: FASEB J Date: 2015-07-21 Impact factor: 5.191
Authors: Jildau Bouwman; Jack Twe Vogels; Suzan Wopereis; Carina M Rubingh; Sabina Bijlsma; Ben van Ommen Journal: BMC Med Genomics Date: 2012-01-06 Impact factor: 3.063
Authors: P C Calder; N Ahluwalia; R Albers; N Bosco; R Bourdet-Sicard; D Haller; S T Holgate; L S Jönsson; M E Latulippe; A Marcos; J Moreines; C M'Rini; M Müller; G Pawelec; R J J van Neerven; B Watzl; J Zhao Journal: Br J Nutr Date: 2013-01 Impact factor: 3.718
Authors: Femke P M Hoevenaars; Charlotte M M Berendsen; Wilrike J Pasman; Tim J van den Broek; Emmanuel Barrat; Iris M de Hoogh; Suzan Wopereis Journal: Nutrients Date: 2020-09-15 Impact factor: 5.717
Authors: Mara P H van Trijp; Sophie Schutte; Diederik Esser; Suzan Wopereis; Femke P M Hoevenaars; Guido J E J Hooiveld; Lydia A Afman Journal: J Nutr Date: 2021-03-11 Impact factor: 4.798
Authors: Berit Boshuizen; Carmen Vidal Moreno de Vega; Lorie De Maré; Constance de Meeûs; Jean Eduardo de Oliveira; Guilherme Hosotani; Yannick Gansemans; Dieter Deforce; Filip Van Nieuwerburgh; Catherine Delesalle Journal: Front Vet Sci Date: 2021-04-12
Authors: Iris M de Hoogh; Barbara L Winters; Kristin M Nieman; Sabina Bijlsma; Tanja Krone; Tim J van den Broek; Barbara D Anderson; Martien P M Caspers; Joshua C Anthony; Suzan Wopereis Journal: Nutrients Date: 2021-05-22 Impact factor: 5.717
Authors: James C Griffiths; Jan De Vries; Michael I McBurney; Suzan Wopereis; Samet Serttas; Daniel S Marsman Journal: Eur J Nutr Date: 2020-09 Impact factor: 5.614